• Reserpine (N1867): Technical Guide for Laboratory Research

  2026-06-12

  Reserpine is a high-purity, bioactive compound designed for research into neurotransmitter depletion and antihypertensive mechanisms. It is not suitable for diagnostic, clinical, or veterinary use, and requires precise preparation and storage to ensure experimental reliability.

• Distinct DNA Repair Pathways Enable R2 Retrotransposon Integ

  2026-06-12

  McIntyre et al. reveal that multiple host DNA repair mechanisms, including Polymerase θ-mediated end-joining and Shieldin/CST-Polα-primase fill-in synthesis, facilitate either intact or truncated insertions by R2 retrotransposon protein in human cells. These findings clarify how non-LTR retrotransposons achieve stable genome integration and inform strategies for precise genome engineering.

• HEY2 Regulates Mitochondrial Respiration in Cardiac Function

  2026-06-11

  This study uncovers how the transcriptional repressor HEY2 orchestrates mitochondrial oxidative metabolism to maintain cardiac homeostasis. By identifying the HEY2/HDAC1-Ppargc1/Cpt module as a regulator of energy metabolism in cardiomyocytes, the research provides a mechanistic link between transcriptional repression and heart failure pathogenesis, with broad implications for metabolic cardiac disease models.

• Aromatase (CYP19) Inhibition by Lamotrigine and Other AEDs

  2026-06-11

  Jacobsen et al. investigated the inhibitory effects of twelve antiepileptic drugs—including Lamotrigine—on human aromatase (CYP19), an enzyme crucial for estrogen biosynthesis. Their findings reveal that several AEDs, notably including Lamotrigine, can reduce aromatase activity in vitro, highlighting important implications for endocrine health during epilepsy treatment.

• Sulfo-NHS-Biotin in High-Resolution Secretome Profiling

  2026-06-10

  Explore how Sulfo-NHS-Biotin empowers advanced, single-cell protein labeling for secretome analysis, bridging biotinylation chemistry with next-generation cell-based assays. Uncover new scientific insights and practical guidance for leveraging this protein labeling reagent.

• N1-Methyl-Pseudouridine-5'-Triphosphate: RNA Stability and T

  2026-06-10

  N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) enhances RNA stability and translation efficiency in vitro. This modified nucleotide, supplied by APExBIO, is pivotal for mRNA vaccine development and RNA research workflows. Benchmarked purity and storage guidance ensure optimal experimental outcomes.

• Lung-Targeted, Lyophilized FNPs Advance mRNA Delivery Stabil

  2026-06-09

  Cao et al. introduce five-element nanoparticles (FNPs) for lung-specific mRNA delivery, uniquely achieving six months' stability at 4°C after lyophilization. This approach addresses long-standing storage and delivery barriers, with implications for developing accessible mRNA-based therapies for respiratory diseases.

• Cabozantinib (XL184) in RCC: Workflows, Adaptation & Trouble

  2026-06-09

  Cabozantinib (XL184) stands out as a multi-target RTK inhibitor enabling phosphoproteomic dissection and advanced adaptation studies in renal cell carcinoma (RCC). This guide details best-practice protocols, adaptation insights, and common troubleshooting tactics—empowering researchers to model, measure, and overcome kinase inhibitor adaptation with confidence.

• Transdermal PTEN mRNA Delivery via HA-LNPs in Melanoma Thera

  2026-06-08

  This study presents a hyaluronated lipid nanoparticle (HA-LNP) platform for the transdermal delivery of PTEN mRNA in melanoma, enabling efficient restoration of tumor suppressor activity and immune activation. The approach addresses key limitations of viral and PEG-based delivery systems, offering a clinically relevant advance for localized mRNA-based immunotherapy.

• Phosphatase Inhibitor Cocktail 2: Precision in Neurodegenera

  2026-06-08

  Explore how Phosphatase Inhibitor Cocktail 2 ensures accurate protein phosphorylation preservation in neurodegeneration research. This article offers a unique, in-depth analysis of nucleolar proteostasis, SIRT6-driven pathways, and advanced protocol guidance for signaling studies.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Workflows for Precision Immu

  2026-06-07

  EZ Cap™ Mouse IL-12 mRNA (m1Ψ) empowers researchers to achieve extrahepatic cytokine delivery using advanced virus-mimicking nanoparticle systems. This guide details practical workflows, protocol enhancements, and troubleshooting to unlock high-efficiency mRNA-based immunotherapy and gene expression studies.

• TAI-1: Unveiling Hec1 Inhibition for Advanced RB1-Deficient

  2026-06-06

  Explore TAI-1, a first-in-class Hec1 inhibitor, and its profound impact on apoptotic cell death induction and cancer cell proliferation inhibition, with a deep dive into RB1-deficient models and practical assay insights not covered in prior articles.

• Optimizing Mucin Detection with Alcian Blue & Nuclear Fast R

  2026-06-05

  This article provides a scenario-driven, evidence-based guide for optimizing mucin and chondrogenic differentiation staining using the Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5 (SKU K1188). We address real laboratory challenges, benchmarking the kit’s workflow and data reliability for biomedical researchers. Explore practical solutions grounded in literature and validated best practices.

• Haloprogin’s Broad-Spectrum Antifungal Mechanisms: Insights

  2026-06-05

  The landmark 1970 study by Harrison et al. established Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene) as a potent topical antifungal with unique efficacy against dermatophytes, yeasts, and certain Gram-positive bacteria. These findings advanced the understanding of broad-spectrum topical agents and informed the design of reproducible infection models for dermatophytosis and Candida albicans research.

• N1-Methyl-Pseudouridine-5'-Triphosphate: Redefining RNA Stab

  2026-06-04

  Explore how N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) advances RNA stability and translational efficiency in mRNA vaccine development. This analysis delivers novel insights beyond typical product literature, connecting state-of-the-art research to practical assay optimization.

450 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page